New Practice Leaders Appointed
RESEARCH TRIANGLE PARK, N.C., April 22 /PRNewswire/ -- Quintiles
Transnational Corp. today announced the appointment of three new practice
leaders and a business development head as part of its expanding Quintiles
Consulting business, which provides pharmaceutical, biotech and medical
device companies with strategic guidance to maximize potential and minimize
risk from early discovery through commercialization.
Quintiles Consulting is expanding its current services and building a
premier global consulting organization to provide strategic, operational
and technical advice to pharmaceutical, biotechnology and medical device
companies. The organization will focus on market leading issues and address
client needs in three practice areas: Product Development and
Commercialization, Regulatory and Quality, and Market Access.
The new leadership team members are:
John Doyle, Dr.P.H., M.P.H., Practice Leader, Market Access, U.S. -
Doyle leads the U.S. Market Access practice, focusing on market access
strategy, health economic assessments, outcomes research, and pricing and
reimbursement strategy and support. Doyle will work collaboratively with
Dr. Jacco Keja of the Netherlands-based Market Access practice to build the
business globally, as well as expand and deepen the group's service
offerings.
Doyle joins Quintiles from Analytica International, a health economics
and market access consulting firm he co-founded and led as President. Prior
to that, Doyle directed the Oncology and Immunology Economics Research
Group at Bristol-Myers Squibb. Since 1993, Doyle has authored more than 50
original research articles, in a variety of therapeutic areas, with a
special focus in cardiology, oncology and ophthalmology. He has consulted
with global pharmaceutical and biotech firms on strategic concerns
regarding product development, pricing, reimbursement, market valuation and
other commercialization issues.
Adrian K. McKemey, Ph.D., Practice Leader, Product Development and
Commercialization, U.S. - McKemey leads Quintiles Consulting's Product
Development and Commercialization practice, focusing on business
transformation, portfolio management, risk partnering, scenario planning
and outsourcing strategies.
McKemey was most recently a Principal with the Boston Consulting Group
(BCG), working in the Health Care practice and the BCG Strategy Institute.
Since 2000, he has helped large pharmaceutical clients optimize product
research and development and commercialization through setting strategic
direction, developing science policy, reengineering business processes and
managing organizational change. Prior to BCG, McKemey was a particle
physicist, a tenured faculty member at Brunel University in London and a
visiting professor at Stanford University, where he consulted to
pharmaceutical and diagnostic companies on commercializing his research.
Jim Featherstone, Ph.D., Practice Leader, Regulatory and Quality and
Product Development and Commercialization, Europe - Featherstone will grow
the Product Development and Commercialization practice in Europe, as well
as oversee and expand the existing regulatory and quality consulting
services in Europe.
Featherstone joins Quintiles from Wood Mackenzie, a leading business
intelligence and strategy consulting services company based in the U.K.,
where he was the Global Head of Consulting for the Pharmaceuticals and
Biotechnology practice. Featherstone joined Wood Mackenzie in 2000 to build
the life sciences strategic consulting practice, defining the overall
strategy and executing growth in the European and U.S. markets. Prior to
this, Featherstone was with the pharmaceutical division of British
Petroleum, which he joined after a distinguished academic career.
Matt Eberhart, MBA, Vice President, Business Development - Eberhart is
responsible for establishing a global business development framework,
leading the business development efforts in the U.S. and serving as the
internal liaison to the broader Quintiles organization.
Eberhart has worked with a number of emerging professional services
companies in the life sciences industry, building and managing sales and
marketing organizations. Previously, Eberhart was an executive management
team member at Katalyst, a privately held venture capital and advisory
firm. He has also served as a Senior Manager and European Leadership Team
member for Deloitte Consulting's Life Sciences Practice.
"Each new member of the team brings strong consulting practice-building
skills, entrepreneurial capabilities and deep life sciences industry
knowledge," said Jay Norman, President of Quintiles Consulting. "Quintiles
is well positioned to become the premier global provider of strategic
consulting to the life sciences industry."
About Quintiles Consulting
Quintiles Consulting works with pharmaceutical, biotech and medical
device companies to maximize potential and minimize risk from discovery
through development and commercialization by providing expert strategic,
operational and technical advice. Building on the global reach and
expertise of Quintiles Transnational, Quintiles Consulting practice areas
include Product Development and Commercialization, Regulatory and Quality,
and Market Access. Quintiles Consulting has full-time consultants based
across the U.S. and Europe to serve its global clients. For more
information, please visit http://www.quintiles.com/consulting .
About Quintiles
Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, financial partnering and commercialization for the
biotechnology and healthcare industries. With more than 20,000 employees
and offices in more than 50 countries, it is focused on providing
customer-centric solutions that are the gold standard of the industry. For
more information, please visit the company's Web site at http://www.qtrn.com .
SOURCE Quintiles Transnational Corp.
 back to top
Related links:
http://www.quintiles.com
http://www.qtrn.com http://www.quintiles.com/consulting
CONTACT:
Mari Mansfield, Media Relations of Quintiles
Transnational Corp., +1-919-998-2639 (office), +1-919-259-3298
(mobile), mari.mansfield@quintiles.com
|
